Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

December 16, 2019

Experience

Roche obtains approval for $4.3 billion acquisition of Spark Therapeutics

Davis Polk advised Roche on its approximately $4.3 billion acquisition of Spark Therapeutics, Inc., including coordinating all international regulatory filings. The acquisition was…

April 30, 2019

Experience

Antitrust advice to Ingersoll Rand on transaction with Gardner Denver

Davis Polk is providing antitrust and competition advice to Ingersoll-Rand plc in connection with the approximately $15 billion combination of its Industrial segment with Gardner Denver…

October 11, 2018

Experience

Aetna receives DOJ approval of $77 billion acquisition by CVS Health

Davis Polk is advising Aetna in connection with an agreement with the U.S. Department of Justice that allows it to proceed with its proposed $77 billion acquisition by CVS Health and its…